Effect of Multiple Doses of Sparsentan on the Single-Dose Pharmacokinetics of Dapagliflozin: Open-Label Drug-Drug Interaction Study in Healthy Adults

Authors
Category Primary study
JournalJournal of the American Society of Nephrology
Year 2022
This article has no abstract
Epistemonikos ID: 2abf73cdc8751f98d8cb73a05cc72fcb7a0ce105
First added on: Feb 15, 2025